BLIS Technologies Ltd

PROBIOTIC PIONEERS FOR A HEALTHIER YOU

BLIS Technologies Limited was founded on the ground-breaking research of Professor John Tagg (University of Otago, New Zealand) and the discovery of the oral probiotic strains BLIS K12™ and BLIS M18™. Our strains are backed by over 30 years of robust research, over 70 clinical trials and an IP-protected supply chain. We offer partners both ingredient and finished products within broad health areas, including immunity, teeth & gums, mouth, throat and oral health.